Jody Engel, MScA

Country Manager Canada

Knight Therapeutics Inc.

Jody has more than 15 years of experience in the pharmaceutical industry spread across business development, operations, supply chain, marketing and market research. She started her career in market research roles followed by a move into business development at Paladin Labs where she concluded multiple deals in various therapeutic areas. Jody transitioned into marketing for a successful product launch and management training program and then had the opportunity to lead out-licensing at a Montreal-based biotechnology company prior to joining Knight Therapeutics. After leading and executing multiple product deals for the Canadian market at Knight, Jody transitioned into her current senior role where she is responsible for overseeing the Canadian business.


All Sessions by Jody Engel, MScA

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

Agenda: Day 2 Oct 6, 2020

12:00 pm

12:00 pm

Presentation: QUEBEC UPDATE

Prepare for the Potential National Implications of Québec’s New PLA System

In early summer 2021, INESSS announced a change in their guidelines for listing applications. Investigate how these revisions could potentially be picked up throughout the rest of the country, and arm your team with the knowledge to prepare for potential changes by:

  • Reviewing the learnings to-date in the Québec market

Understanding why INESSS / Québec

  • were driven to institute these particular changes
  • Gaining valuable insight into specifics you may have missed

Position your company to succeed in an uncertain environment with a solid public PLA strategy